Inventor
HIDEKAZU TOKUHARA
Inventor
JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes9%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07KPeptides5%
PatentTitleYear
12,435,063Nitrogen containing heterocycles as CDK12 inhibitors202511,851,449Heterocyclic amide compounds having an RORvt inhibitory action202311,584,737Heterocyclic compound202311,407,748Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function202211,274,101Heterocyclic compound202211,230,545Heterocyclic compound2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (6)· patent assignee history
2022–2025Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 6 | 2022–2025 |